Compared with nonusers, adults taking GLP-1s had a: 17 percent lower risk of venous thromboembolism, or blood clots in the veins 31 percent lower risk of pulmonary embolism, a potentially life-threatening clot that travels to the lungs 21 percent lower risk of going to the emergency department 44 percent lower risk of all-cause mortality (death from any cause) Researchers also observed lower stroke rates among GLP-1 users, although this difference didnt reach statistical significance
Theres also a third strategy, eating lente carbohydrates, from the Latin lentus for slow
But they are: not a cure not metabolically neutral not a substitute for healthy lifestyle & healthspan medicine #GLP1 #CardiometabolicHealth #ObesityMedicine #PreventiveCardiology #Longevity #EvidenceBasedMedici Liesbeth Van RossumLiesbeth Van Rossum is an Influencer Professor of Medicine, internist-endocrinologist at Erasmus MC | European clinical lead obesity and diabetes at the European Society of Endocrinology 2021-2025 | obesity, stress and glucocorticoids | Linkedin Top Voice 49,921 followers
Rogaine increases blood flow
These findings have positioned FOXO4-DRI as one of the most mechanistically specific senolytic peptides currently available for research purposes, distinguishing it from small-molecule senolytics that operate through broader cellular pathways
The liver wasn't the problem, turns out it was the symptom